COVID-19 vaccines
Alibaba Group Holding Ltd. faced a devastating day on the market as its shares plummeted lower after Chinese regulators set their sights on the tech giant in a fresh attack on the financial empire of billionaire Jack Ma. The turbulence sent shockwaves through the stock market, with several other tech
COVID-19 vaccines
Regulatory Affairs Professionals Society released daily news and intelligence briefings, covering major regulatory, biopharma, and medtech stories from around the globe. Key storylines include the US CDC panel endorsing Moderna vaccine for Americans, vaccine distribution efforts, and approvals of new treatments and medications. Key Takeaways: * The US CDC panel has
COVID-19 vaccines
Investors cheered news of progress toward a fresh stimulus package on Thursday, sending stock futures higher as the market opened. Several stocks made notable moves, driven by a combination of positive earnings reports, mergers and acquisitions, and analyst upgrades. Here is a summary of the top movers in premarket trading
COVID-19 vaccines
New Jersey has started administering the Pfizer COVID-19 vaccine to frontline healthcare workers, with Maritza Beniquez, a 56-year-old emergency room nurse, becoming the first New Jerseyan to receive the vaccine. The vaccine, developed by Pfizer through a partnership with BioNTech, requires two shots and is expected to vaccinate 38,000
COVID-19 vaccines
The recent FDA review of Pfizer's coronavirus vaccine found insufficient data to conclude whether the vaccine is safe for children under 16, pregnant women, and immunocompromised individuals. The review also questions the safety of vaccinating individuals who previously got COVID-19, particularly if they have lingering symptoms. Experts worry
COVID-19 vaccines
The Trump administration's decision not to purchase additional doses of Pfizer's coronavirus vaccine last summer, when the option was available, has raised concerns that it may delay the delivery of a second batch of doses until the company fulfills its orders to other countries. This revelation
COVID-19 vaccines
FDA Commissioner Stephen Hahn met with White House chief of staff Mark Meadows for the second day in a row on Wednesday, amid growing frustration from President Trump and White House officials over the delayed approval of the Pfizer coronavirus vaccine in the US. The meeting comes as the UK
COVID-19 vaccines
Moncef Slaoui, the chief science advisor to President Donald Trump's Operation Warp Speed, has emphasized the importance of taking the COVID-19 vaccine, citing a "social responsibility" to do so. In a recent interview with The Washington Post, Slaoui urged Americans to think critically about the vaccine
COVID-19 vaccines
Major U.S. stock markets closed Friday with notable gains as investors responded to encouraging news on the Pfizer coronavirus vaccine, along with growing optimism about economic recovery. The Dow Jones Industrial Average, despite a brief dip, ended the week up by 37 points, or 0.13%, at 29,910.
COVID-19 vaccines
Investors welcomed further progress on the development of a coronavirus vaccine, but were hard-pressed to ignore rising infection rates and curbs on businesses that could hamper an economic recovery. Stock futures rose Monday as pharmaceutical companies AstraZeneca and Pfizer announced positive results from late-stage trials of their respective vaccines. Meanwhile,
COVID-19 vaccines
The world is witnessing a mass effort to develop effective Covid-19 vaccines, with several promising candidates in the final stages of testing. Pfizer, Moderna, and the University of Oxford / AstraZeneca are among the leading players in the vaccine development race, with the UK's Vaccine Taskforce securing a total
COVID-19 vaccines
The Oxford-AstraZeneca vaccine, which is currently in phase two trials, has demonstrated safety and an immune response similar to younger groups among all adults, including those over 70. This has raised hopes that the vaccine can protect age groups most at risk from COVID-19. The trial results suggest that the
